Published in Clin Psychol (New York) on June 08, 2010
Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry (2013) 2.00
Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions. Biol Psychiatry (2015) 0.79
Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med (2008) 10.48
Emotional processing of fear: exposure to corrective information. Psychol Bull (1986) 8.03
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull (2007) 6.84
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry (2004) 5.26
Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry (2008) 3.63
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA (2000) 3.52
Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry (2006) 3.45
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci (1992) 3.40
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry (2005) 3.38
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry (2002) 3.15
D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry (2007) 3.03
Experience-dependent gene expression in the rat hippocampus after spatial learning: a comparison of the immediate-early genes Arc, c-fos, and zif268. J Neurosci (2001) 2.97
Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology (2005) 2.92
The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev (1997) 2.88
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry (2006) 2.77
Adrenergic transmission facilitates extinction of conditional fear in mice. Learn Mem (2004) 2.36
Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology (2001) 2.23
Enhanced human memory consolidation with post-learning stress: interaction with the degree of arousal at encoding. Learn Mem (2003) 2.19
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry (2003) 2.17
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry (2008) 2.17
Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry (1993) 2.08
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry (2008) 2.03
Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry (2006) 2.00
Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A (2006) 2.00
Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry (2004) 1.94
Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry (1999) 1.89
Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus. Proc Natl Acad Sci U S A (2005) 1.83
Glucocorticoid effects on memory function over the human life span. Dev Psychopathol (2001) 1.83
D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci (2004) 1.75
Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology (Berl) (2008) 1.66
Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A (2006) 1.64
Stress facilitates consolidation of verbal memory for a film but does not affect retrieval. Behav Neurosci (2006) 1.62
The effects of safety-seeking behavior and guided threat reappraisal on fear reduction during exposure: an experimental investigation. Behav Res Ther (2002) 1.61
Hypercortisolemia and depression. Psychosom Med (2005) 1.60
D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry (2005) 1.53
Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation. Proc Natl Acad Sci U S A (1999) 1.52
Networks of neurons, networks of genes: an integrated view of memory consolidation. Neurobiol Learn Mem (2007) 1.51
Amygdala regulation of immediate-early gene expression in the hippocampus induced by contextual fear conditioning. J Neurosci (2006) 1.35
Postreactivation glucocorticoids impair recall of established fear memory. J Neurosci (2006) 1.35
Emotional processing and outcome of imaginal flooding therapy in Vietnam veterans with chronic posttraumatic stress disorder. Compr Psychiatry (1997) 1.34
Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications. Learn Mem (2004) 1.31
Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? Biol Psychiatry (2002) 1.25
Memory enhancement of classical fear conditioning by post-training injections of corticosterone in rats. Neurobiol Learn Mem (2004) 1.23
Endogenous cortisol level interacts with noradrenergic activation in the human amygdala. Neurobiol Learn Mem (2006) 1.21
Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety (2009) 1.21
Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol (2004) 1.20
Basolateral amygdala noradrenergic activity mediates corticosterone-induced enhancement of auditory fear conditioning. Neurobiol Learn Mem (2006) 1.18
The effect of yohimbine on the extinction of conditioned fear: a role for context. Behav Neurosci (2007) 1.16
HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety (2007) 1.16
Endogenous cortisol elevations are related to memory facilitation only in individuals who are emotionally aroused. Psychoneuroendocrinology (2005) 1.14
Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology (1993) 1.08
Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism. Br J Pharmacol (2000) 1.06
High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response. Neuropsychopharmacology (2007) 1.06
Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast (2007) 1.05
Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther (1999) 1.02
The promise of extinction research for the prevention and treatment of anxiety disorders. Biol Psychiatry (2006) 1.00
Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis (1998) 1.00
Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats. Neuropsychopharmacology (2006) 1.00
Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. Br J Psychiatry Suppl (1998) 1.00
Midazolam in the reduction of surgical stress: a randomized clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.00
Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder. Ann N Y Acad Sci (2006) 0.98
Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. J Consult Clin Psychol (2004) 0.97
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. J Consult Clin Psychol (2008) 0.97
Glucocorticoids alter calcium conductances and calcium channel subunit expression in basolateral amygdala neurons. Eur J Neurosci (2002) 0.96
Glucocorticoid enhancement of memory consolidation in the rat is blocked by muscarinic receptor antagonism in the basolateral amygdala. Eur J Neurosci (2000) 0.96
Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. J Anxiety Disord (2009) 0.96
Salivary cortisol response during exposure treatment in driving phobics. Psychosom Med (2003) 0.94
Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam. Psychoneuroendocrinology (2006) 0.93
Salivary cortisol and short and long-term memory for emotional faces in healthy young women. Psychoneuroendocrinology (2004) 0.93
One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission. Behav Res Ther (2005) 0.92
Effects of some new antidepressant drugs on the glucocorticoid receptor-mediated gene transcription in fibroblast cells. Pharmacol Rep (2005) 0.92
Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. CNS Spectr (2007) 0.92
Glucocorticoid receptors in the basolateral nucleus of amygdala are required for postreactivation reconsolidation of auditory fear memory. Eur J Neurosci (2007) 0.91
What happens in the course of body exposure? Emotional, cognitive, and physiological reactions to mirror confrontation in eating disorders. J Psychosom Res (2007) 0.90
The effect of attributional processes concerning medication taking on return of fear. J Consult Clin Psychol (2008) 0.90
Midazolam inhibits long-term potentiation through modulation of GABAA receptors. Neuropharmacology (1996) 0.90
The pattern of subjective anxiety during in-session exposures over the course of cognitive-behavioral therapy for clients with social anxiety disorder. Behav Ther (2008) 0.89
Microinfusions of flumazenil into the basolateral but not the central nucleus of the amygdala enhance memory consolidation in rats. Neurobiol Learn Mem (1999) 0.88
Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience (2003) 0.87
Intra-hippocampal microinjections of anisomycin did not block glucocorticoid-induced impairment of memory retrieval in rats: an evidence for non-genomic effects of glucocorticoids. Behav Brain Res (2006) 0.85
Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment. Biol Psychiatry (1997) 0.85
Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. J Pharmacol Exp Ther (1998) 0.85
Bicuculline administered into the amygdala after training blocks benzodiazepine-induced amnesia. Brain Res (1997) 0.84
Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database Syst Rev (2009) 0.83
[Posttrial injections of corticosterone in dorsal hippocampus of the BALB/c mouse facilitate extinction of appetitive operant conditioning in the Skinner box]. C R Seances Acad Sci III (1982) 0.83
Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder. Psychopharmacology (Berl) (2004) 0.83
Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity? Pharmacopsychiatry (1986) 0.82
Microinjections of the dopamine D2 receptor antagonist sulpiride into the medial prefrontal cortex attenuate glucocorticoid-induced impairment of long-term memory retrieval in rats. Neurobiol Learn Mem (2006) 0.82
The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam. Horm Metab Res (1994) 0.81
Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder. Cogn Affect Behav Neurosci (2005) 0.81
Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. J Clin Endocrinol Metab (1997) 0.80
Neuroendocrine effects of benzodiazepines. J Psychiatr Res (1990) 0.80
The effect of elevated blood cortisol levels on the extinction of a conditioned stress response in rainbow trout. Horm Behav (2006) 0.79
Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biol Psychiatry (1991) 0.79
Adrenoceptor mechanisms underlying imipramine-induced memory deficits in rats. J Psychopharmacol (2003) 0.79
Fluoxetine and 8-OH-DPAT in the lateral septum enhances and impairs retention of an inhibitory avoidance response in rats. Physiol Behav (1992) 0.79
Catecholaminergic, neuroendocrine and anxiety responses to acute psychological stress in healthy subjects: influence of alprazolam administration. Neuropsychobiology (1996) 0.79
Benzodiazepine premedication may attenuate the stress response in daycase anesthesia: a pilot study. Can J Anaesth (2002) 0.78
Modifying Exposure-Based CBT for Cambodian Refugees with Posttraumatic Stress Disorder. Cogn Behav Pract (2006) 0.88